Calcitonin and calcium therapy in an infant with osteogenesis imperfecta congenita
Abstract
Calcitonin has been helpful in the treatment of osteogenesis imperfecta tarda inhibiting bone mineral resorption. The experience with salmon calcitonin in the early treatment of osteogenesis imperfecta congenita is very limited. Here we report an infant with this disorder treated with calcitonin from 3 to 15 months of age with clinical and radiographic improvement.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Development of a crushable foam model for human trabecular bone
- Data-driven motion compensation in HR-pQCT.
- Modeling of structure, quality, and function in the orthodontic patient
- Exploring the mechanism of Heidihuang Pill in the treatment of osteoporosis based on network pharmacology, molecular docking, and experimental validation
- Effect of fabric on the accuracy of computed tomography-based finite element analyses of the vertebra
- Use of interventions involving virtual reality tasks during the climacteric: a systematic review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.